Machine learning to further improve the decision which boar ejaculates to process into artificial insemination doses.


Journal

Theriogenology
ISSN: 1879-3231
Titre abrégé: Theriogenology
Pays: United States
ID NLM: 0421510

Informations de publication

Date de publication:
01 Mar 2020
Historique:
received: 16 07 2019
revised: 31 10 2019
accepted: 23 12 2019
pubmed: 14 1 2020
medline: 25 11 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

Current artificial insemination (AI) laboratory practices assess semen quality of each boar ejaculate to decide which ones to process into AI doses. This decision is aided with two, world-wide used, motility parameters that come available through computer assisted semen analysis (CASA). This decision process, however, still results in AI doses with variable and sometimes suboptimal fertility outcomes (e.g., small litter size). The hypothesis was that the decision which ejaculates to process into AI doses can be improved by adding more data from CASA systems, and data from other sources, in combination with a data-driven model. Available data consisted of ejaculates that passed the initial decision, and thus, were processed into AI doses and used to inseminate sows. Data were divided into a training set (6793 records) and a validation set (1191 records) for model development, and an independent test set (1434 records) for performance assessment. Gradient Boosting Machine (GBM) models were developed to predict four fertility phenotypes of interest (gestation length, total number born, number born alive, and number of stillborn piglets). Each fertility phenotype was considered as a numeric and as a binary outcome parameter, totaling to eight different fertility phenotypes. Data used to further improve the decision process originated from four sources: 1) CASA information, 2) boar ejaculate information, 3) breeding value estimations, and 4) weather information. These data were used to create seven prediction sets, where each new set added parameters to the ones included in the previous set. The GBM models predicted fertility phenotypes with low correlations (for numeric phenotypes) and area under the curve values (for binary phenotypes) on the test data. Hence, results demonstrated that a combination of more data and GBM did not enable further improvement of the AI dose quality checks, resulting in the rejection of our hypothesis. However, our study revealed parameters affecting boar ejaculate fertility which were not used in today's decision process. These parameters (listed in the top 10 in at least four GBM models) included one parameter associated with boar ejaculate information, two with breeding value estimations, five with CASA information, and one with weather information. These parameters, therefore, should be further investigated for their potential value when assessing the quality of boar ejaculates in daily routine AI doses processing.

Identifiants

pubmed: 31927416
pii: S0093-691X(19)30561-8
doi: 10.1016/j.theriogenology.2019.12.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112-121

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The dataset used for this analysis is based on the results of the ejaculates of boars located at the centers of Varkens KI Nederland (Vught, The Netherlands). M.L.W.J. Broekhuijse was employed at Topigs Norsvin till May 31st, 2019. Varkens KI Nederland is distributor of Topigs Norsvin genetics in the Netherlands. The other authors do not have any conflicts of interest to declare.

Auteurs

Claudia Kamphuis (C)

Wageningen University & Research, Animal Breeding and Genomics, P.O. Box 338, 6700 AH, Wageningen, the Netherlands. Electronic address: claudia.kamphuis@wur.nl.

Pascal Duenk (P)

Wageningen University & Research, Animal Breeding and Genomics, P.O. Box 338, 6700 AH, Wageningen, the Netherlands.

Roel Franciscus Veerkamp (RF)

Wageningen University & Research, Animal Breeding and Genomics, P.O. Box 338, 6700 AH, Wageningen, the Netherlands.

Bram Visser (B)

Hendrix Genetics Research, Technology & Services B.V., Spoorstraat 69, 5831 CK, Boxmeer, the Netherlands.

Gurnoor Singh (G)

Radboud University Medical Center, The Centre for Molecular and Biomolecular Informatics, Nijmegen, the Netherlands.

Annette Nigsch (A)

Wageningen University & Research, Department of Quantitative Veterinary Epidemiology, P.O. Box 338, 6700 AH, Wageningen, the Netherlands.

Rudi Maria De Mol (RM)

Wageningen University & Research, Animal Welfare & Adaptation, P.O. Box 338, 6700 AH, Wageningen, the Netherlands.

Marleen Leonarda Wilhelmina Johanna Broekhuijse (MLWJ)

Topigs Norsvin Research Center, P.O. Box 43, 6640 AA, Beuningen, the Netherlands.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH